Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/25/11 → 2/28/14 |
Funding
- Cephalon Inc: $12,058.00
An Open-Label Study to Determine the Maximum Tolerated Dose and Evaluate the Safety and Efficacy of CEP-18770 in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
- Monohan, Gregory (PI)